English | Spanish
ecancer
Login Register

For the latest ecancer COVID-19 resources, click on this link

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Conferences
  • About us
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+ -
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [214]
News [995]
Articles [36]
Editorials [3]
Conferences [40]
elearning [6]
Ovarian cancer drug offers new genetically targeted approach against a range of cancers
Ovarian cancer drug offers new genetically targeted approach against a range of cancers
COVID-19 and cancer: Useful resources
COVID-19 and cancer: Useful resources
'Undruggable' cancer protein becomes druggable, thanks to shrub
'Undruggable' cancer protein becomes druggable, thanks to shrub
Research sheds new light on pancreatic cancer metastasis
Research sheds new light on pancreatic cancer metastasis
Innovative technique developed to destroy cancerous kidney cells
Innovative technique developed to destroy cancerous kidney cells
Increased risk of liver cancer in patients with non-alcoholic fatty liver
Increased risk of liver cancer in patients with non-alcoholic fatty liver
Potential ways to improve survival for cancer patients who receive fragmented care
Potential ways to improve survival for cancer patients who receive fragmented care
AACR 2021: CREB1 identified as potential therapeutic target for the treatment of pancreatic cancer
AACR 2021: CREB1 identified as potential therapeutic target for the treatment of pancreatic cancer
AACR 2021: FDA-approved selpercatinib shows clinical benefits for RET fusion-positive cancers beyond lung and thyroid cancers
AACR 2021: FDA-approved selpercatinib shows clinical benefits for RET fusion-positive cancers beyond...
AACR 2021: Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer
AACR 2021: Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer
<12345...100>
Donate to ecancer

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
The content on this site is intended for healthcare professionals only
  • Follow ecancer on Facebook
  • Follow ecancer on Twitter
  • Follow ecancer on Linkedin
  • Subscribe to the ecancer YouTube channel
© 2021 ecancer, all rights reserved
UK registered charity number: 1176307